The present study which is the first to be designed to assess the impact of rt-PA treatment on circulating BDNF levels in stroke patients, revealed higher serum BDNF levels in rt-PA treated than in non-treated stroke patients at least from day 1 to 7 after stroke onset. This evidence concerns the gene BDNF and Stroke.